SCHEMBL6500174

SCHEMBL6500174

Cc1cc(F)ccc1-c1ccc(-n2cc(NC(N)=O)c(C(N)=O)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.41
KDM4E B2RXH2 4/20 0.40
MAPT P10636 2/20 0.40
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
LRRK2 Q5S007 1/20 0.39
LMNA P02545 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
ABL1 P00519 1/20 0.37
NR3C2 P08235 1/20 0.36
GRIN2B Q13224 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470351 0.89 KDM4E (0.42) ITKKDM4EMAPTIDO1TDO2
SCHEMBL6503754 0.89 KDM4E (0.42) ITKKDM4EMAPTIDO1TDO2
SCHEMBL6499798 0.89 SCN9A (0.48) ITKKDM4EMAPTALDH1A1MEN1
SCHEMBL6470611 0.86 ITK (0.40) ITKKDM4EMAPTIDO1TDO2
SCHEMBL6502483 0.86 ITK (0.41) ITKKDM4EMAPTALDH1A1HTT
SCHEMBL6467401 0.86 KDM4E (0.41) ITKKDM4EMAPTIDO1TDO2
SCHEMBL6504415 0.85 KDM4E (0.50) ITKKDM4EMAPTALDH1A1MEN1
SCHEMBL6470704 0.85 ITK (0.39) ITKKDM4EMAPTIDO1TDO2
SCHEMBL6499913 0.85 LRRK2 (0.46) ITKKDM4EMAPTIDO1TDO2
SCHEMBL6467527 0.84 KDM4E (0.47) ITKKDM4EMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885KDM4E 2424/4885MAPT 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.